Nectar Lifesciences
BSE: 532649 | NSE: NECLIFE | ISIN: INE023H01027 | Pharmaceuticals
Competition
| Last Price | Market Cap. (Rs. cr.) |
Sales Turnover |
Net Profit | Total Assets | |
| Sun Pharma | 1,450.60 | 30,044.30 | 3,861.55 | 1,265.29 | 5,175.02 |
| Cipla | 328.00 | 26,335.82 | 5,270.54 | 767.83 | 5,290.99 |
| Dr Reddys Labs | 1,099.00 | 18,545.11 | 4,197.53 | 560.89 | 5,899.40 |
| Ranbaxy Labs | 419.30 | 17,628.10 | 4,494.52 | -1,032.33 | 7,442.15 |
| GlaxoSmithKline | 1,666.10 | 14,112.37 | 1,685.56 | 576.57 | 1,546.72 |
| Lupin | 1,335.90 | 11,838.51 | 2,967.13 | 416.97 | 2,320.21 |
| Piramal Health | 410.35 | 8,576.85 | 2,333.46 | 275.32 | 2,165.88 |
| Cadila Health | 586.00 | 7,998.84 | 1,945.72 | 265.91 | 2,052.70 |
| Divis Labs | 598.90 | 7,830.29 | 1,203.49 | 421.26 | 1,314.44 |
| Glenmark | 249.05 | 6,713.92 | 856.11 | 217.93 | 2,291.33 |
| Nectar Life | 27.60 | 420.24 | 731.11 | 54.58 | 1,007.48 |




Online










